At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
Chlorhexidine Gluconatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single Dose Pharmacokinetic Study to Assess the Systemic Exposure of Chlorhexidine From ReadyPrep® CHG (2% Chlorhexidine Gluconate Cloth)
In Brief
A Phase 1 clinical trial evaluating Chlorhexidine Gluconate for Surgical Skin Preparation. Completed, enrolled 12 participants across 1 site.
Detailed Summary
A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgical Skin Preparation
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
Primary CompletionAug 2017
First PostedNov 2017
TodayJul 2026
First PostedNov 6, 2017
Enrollment StartJul 21, 2017
Primary CompletionAug 6, 2017
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 8.7 years ago
Interventions
Chlorhexidine Gluconatedrug
2% CHG